Cadila Receives US FDA Nod For Two Drugs
Zydus Cadila gets final nod from USFDA for anti-bacterial drugПодробнее
Cadila Health; Zydus Gets US FDA Nod For Rivastigmine Tablets, Used To Treat Alzheimer'sПодробнее
Trading Hour | Cadila Health Gains 3% Post US FDA Nod for Renal Druds | CNBC Tv18Подробнее
Zydus Cadila gets USFDA nod for a drugПодробнее
Cadila Health Gets US FDA Nod For Mesalaminea DrugПодробнее
Cadila Health; Zydus Gets US FDA Nod For Potassium Chloride Extended-Release CapsulesПодробнее
CADILA EYES USFDA NOD FOR MORAIYA. Co To Call USFDA For Re-inspection In OctoberПодробнее
Cadila Healthcare’s Moraiya Unit Receives EIR From US FDAПодробнее
PADER Report (Periodic Adverse Drug Experience Report)Подробнее
Zydus Cadila gets DCGI nod to conduct Phase III trials for two-dose COVID vaccineПодробнее
FDA ends emergency use authorization for two drugsПодробнее
Zydus Cadila gets USFDA nod for drug trials to treat chemotherapyinduced anemia India News Time 20Подробнее
Cadila's Baddi Unit Receives 3 US FDA ObservationsПодробнее
Aurobindo Pharma Receives US FDA Approval For Anti-Aids DrugПодробнее
FDA warns to Dollar Tree for receiving 'potentially unsafe drugs'Подробнее
Carcinogens Get Into the Generic U.S. Drug SupplyПодробнее
Sun Pharma Receives US FDA Nod For GlumetzaПодробнее
Zydus cadila gets usfda nod to sell bp lowering drugПодробнее
Filing and Refuse to Receive (RTR) (16of28) Generic Drugs Forum – Apr. 3-4, 2019Подробнее